Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo‐controlled trial

AIMS: Morphine is shown to relieve chronic breathlessness in chronic obstructive pulmonary disease. There are no definitive data in people with heart failure. We aimed to determine the effectiveness and cost‐effectiveness of 12 weeks morphine therapy for the relief of chronic breathlessness in peopl...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Miriam J., Cockayne, Sarah, Currow, David C., Bell, Kerry, Hicks, Kate, Fairhurst, Caroline, Gabe, Rhian, Torgerson, David, Jefferson, Laura, Oxberry, Stephen, Ghosh, Justin, Hogg, Karen J., Murphy, Jeremy, Allgar, Victoria, Cleland, John G.F., Clark, Andrew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989293/
https://www.ncbi.nlm.nih.gov/pubmed/31389157
http://dx.doi.org/10.1002/ehf2.12498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989293/
https://www.ncbi.nlm.nih.gov/pubmed/31389157
http://dx.doi.org/10.1002/ehf2.12498

Ejemplares similares